Investing.com - AbbVie (NYSE:ABBV) reported second quarter earnings that beat analysts' expectations on Friday and revenue that topped forecasts.
The firm reported earnings per share of $2.26 on revenue of $8.26B. Analysts polled by Investing.com expected EPS of $2.2 on revenue of $8.08B. That compared to EPS of $2 on revenue of $8.26B in the same period a year earlier. The company had reported EPS of $2.14 on revenue of $7.83B in the previous quarter.
AbbVie shares gained 2.31% to trade at $68.20 in pre-market trade following the report.
AbbVie shares gained 2.31% to trade at $68.20 in pre-market trade following the report.
For the year, AbbVie shares are down 27.69%, under-performing the S&P 500 which is up 21.26% year to date.
AbbVie follows other major Healthcare sector earnings this month
On Tuesday, July 16, 2019, J&J reported second quarter EPS of $2.58 on revenue of $20.56B, compared to forecasts of EPS of $2.46 on revenue of $20.29B.
Novartis ADR earnings beat analyst's expectations on Thursday, July 18, 2019, with second quarter EPS of $1.34 on revenue of $11.76B. Investing.com analysts expected EPS of $1.21 on revenue of $11.49B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar